All Access Articles |
- FDA Accepts Capricor's BLA for Deramiocel | 2025-03-04 | PHARMACEUTICAL
- Capricor Therapeutics Makes Progress in DMD Treatment | 2025-01-02 | PHARMACEUTICAL
- Capricor Therapeutics Prices Public Offering at $17 per Share | 2024-10-17 | PHARMACEUTICAL